Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DST-101
- Development stage
- Preclinical
- Lead developer
- DelSiTech
- Modality
- Peptides
- Administration
- Subcutaneous
01
Overview
DST-101 is an ultra long-acting therapeutic candidate developed by DelSiTech for the treatment of metabolic diseases. The product utilizes DelSiTech's proprietary Silica Matrix technology, a drug delivery platform that encapsulates active pharmaceutical ingredients—typically peptides or proteins—within a biodegradable, porous silica (silicon dioxide) structure. This formulation is designed to provide a controlled, linear release of the medication over an extended period, potentially lasting several months, following a single subcutaneous injection. By improving the pharmacokinetic profile and reducing the frequency of administration, DST-101 aims to enhance patient compliance and therapeutic outcomes in chronic metabolic conditions. The program is currently in the pharmaceutical development stage, focusing on optimizing the formulation for clinical use.
- Other names
- DST-101DST101DST 101
Beyond the preview
Go deeper on DST-101.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DST-101.